Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Clinigence Holdings ( (NUTX) ) is now available.
At its April 23, 2026 annual meeting, Nutex Health Inc. reported that shareholders representing about 69.29% of eligible common shares participated in voting, reflecting a solid quorum for corporate governance decisions. All seven director nominees were elected to serve until the 2027 annual meeting, reinforcing continuity in the company’s leadership and oversight structure.
Shareholders approved, on an advisory basis, the compensation of the company’s named executive officers, indicating general investor support for current pay practices. Investors also ratified Grant Thornton LLP as Nutex Health’s independent registered public accounting firm for the year ending December 31, 2026, maintaining stability in the company’s financial reporting and audit arrangements.
The most recent analyst rating on (NUTX) stock is a Buy with a $300.00 price target. To see the full list of analyst forecasts on Clinigence Holdings stock, see the NUTX Stock Forecast page.
Spark’s Take on NUTX Stock
According to Spark, TipRanks’ AI Analyst, NUTX is a Neutral.
The score is driven primarily by solid financial performance (notably strong 2025 operating cash flow and improved profitability) and generally constructive earnings-call guidance/capital allocation. These positives are meaningfully offset by weak technicals (bearish trend and momentum) and balance-sheet/IDR-related volatility risks, while valuation is only moderately supportive.
To see Spark’s full report on NUTX stock, click here.
More about Clinigence Holdings
Nutex Health Inc. is a healthcare company, indicated by its annual meeting of stockholders and governance structure typical of U.S. public corporations. The company operates with a board of directors, named executive officers, and uses an independent registered public accounting firm, positioning it within regulated, publicly traded healthcare enterprises.
Average Trading Volume: 206,876
Technical Sentiment Signal: Sell
Current Market Cap: $739.9M
For detailed information about NUTX stock, go to TipRanks’ Stock Analysis page.